Navigation Links
Important fertility mechanism discovered

Scientists in Mainz and Aachen have discovered a new mechanism that controls egg cell fertility and that might have future therapeutic potential. It was revealed by Professor Dr. Walter Stcker of the Institute of Zoology at Johannes Gutenberg University Mainz (JGU) that the blood protein fetuin-B plays an important and previously unknown role in the fertilization of oocytes. Fetuin-B, first identified in the year 2000, is formed in the liver and secreted into the blood stream. During a joint research project with researchers at RWTH Aachen University headed by Professor Dr. Willi Jahnen-Dechent of the Helmholtz Institute for Biomedical Engineering, it was discovered that fetuin-B contributes to egg cell fertility by regulating the hardening of the protective zona pellucida of oocytes. The findings have recently been published in the scientific journal Developmental Cell.

The scientists at Aachen discovered that female mice lacking fetuin-B were infertile even though their ovaries developed normally. But fertility was restored when their ovaries were transplanted in wild-type mice with normal fetuin-B production. "This demonstrates that it was not the ovaries themselves but the plasma protein fetuin-B that determined whether the mice were fertile or not," explained Stcker.

The role played by the plasma protein fetuin-B was decoded in cooperation with the team in Aachen. The mechanism appears to operate as follows: The oocytes of humans and other mammals are surrounded by a protective envelope called the zona pellucida. This envelope hardens immediately after the successful fertilization of the egg cell by a sperm, which means that subsequent sperm are unable to penetrate the ovum, thus preventing multiple fertilization (polyspermy). Polyspermy results in the death of the embryo in many mammals. The hardening of the zona pellucida is triggered by the proteolytic enzyme ovastacin, the function of which Stcker's team in Mainz has been investigating. The protease ovastacin is stored in vesicles within the egg cell and when the first sperm penetrates the ovum, the protease is explosively discharged into the gap between the egg cell and the zona pellucida in what is known as the cortical reaction.

However, small amounts of ovastacin continually seep from unfertilized egg cells and this would cause the zona to harden before the first sperm can penetrate. "It is the role of fetuin-B to ensure that these constantly escaping small quantities of ovastacin are inactivated so that oocytes can be fertilized," Stcker added. "However, once a sperm has penetrated an egg cell, the cortical reaction will be unleashed and the amount of ovastacin will overwhelm the inhibition capacity of fetuin-B and initiate the hardening process."

This is the first time that it has been shown that premature hardening of the zona pellucida can be a cause of infertility. It is thus possible that this could represent the basis for the development of future forms of infertility treatment.


Contact: Dr. Walter Stöcker
Johannes Gutenberg Universitaet Mainz

Related biology news :

1. An important discovery in breast cancer by IRCM researchers
2. Environmental enrichment important factor impacting cell transplantation and brain repair
3. Researchers discover gateway in nucleus has a second important job no one noticed before
4. Stem cell source an important factor, impacting ability to treat myocardial infarction
5. Could the timing of when you eat, be just as important as what you eat?
6. 2 new studies show why biodiversity is important for pollination services in California almond
7. Eliminating useless information important to learning, making new memories
8. Joslin researchers identify important factor in fat storage and energy metabolism
9. Bering Sea study finds prey density more important to predators than biomass
10. The first genome sequence of Chinese plum provides important resource for fruit improvement
11. Discovery of Africa moth species important for agriculture, controlling invasive plants
Post Your Comments:
(Date:11/17/2015)... Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and ... of broadly enabling, pressure cycling technology ("PCT")-based sample preparation ... it has received gross proceeds of $745,000 from an ... "Offering"), increasing the total amount raised to date in ... are expected in the near future. ...
(Date:11/12/2015)... BOSTON , Nov. 12, 2015  A golden ... for Duchenne muscular dystrophy (DMD) has provided a new ... Boston Children,s Hospital, the Broad Institute of MIT and ... Brazil . Cell, ... some dogs "escape" the disease,s effects. The Boston Children,s ...
(Date:11/12/2015)... 2015   Growing need for low-cost, easy ... been paving the way for use of biochemical ... analytes in clinical, agricultural, environmental, food and defense ... in medical applications, however, their adoption is increasing ... continuous emphasis on improving product quality and growing ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... CA (PRWEB) , ... November 25, 2015 , ... ... genomics company uBiome, were featured on AngelList early in their initial angel funding ... an AngelList syndicate for individuals looking to make early stage investments in the ...
(Date:11/24/2015)... 2015 /CNW/ - iCo Therapeutics ("iCo" or "the Company") ... for the quarter ended September 30, 2015. Amounts, ... and presented under International Financial Reporting Standards ("IFRS"). ... said Andrew Rae , President & CEO ... not only value enriching for this clinical program, ...
(Date:11/24/2015)... -- --> --> ... Market by Product & Services (Primer, Probe, Custom Oligos, ... End-User (Research, Pharmaceutical & Biotech, Diagnostic Labs) - Global ... expected to reach USD 1,918.6 Million by 2020 from ... 10.1% during the forecast period. Browse 183 ...
(Date:11/24/2015)... Ltd. (OTCQB: TIKRF) today announced that its Annual General Meeting of Shareholders ... Israel time, at the law offices of Goldfarb Seligman ... Floor, Tel Aviv, Israel . ... to the Board of Directors; , election of Liat ... an amendment to certain terms of options granted to our Chief Executive ...
Breaking Biology Technology: